Clinical trials underrepresent women, children, and adults aged 65 years or older, so diabetes guidelines must be adapted to ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

Users of Tandem Diabetes Care’s insulin pumps now have a new way to monitor the pumps’ data and manage their equipment. After being unveiled during the American Diabetes Association’s annual ...

Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...

SEATTLE — The latest American Association of Clinical Endocrinology (AACE) type 2 diabetes management algorithm uses graphics to focus on individualized care while adding newly compiled information ...

JACKSONVILLE, Fla., May 5, 2023 /PRNewswire/ -- Today, the American Association of Clinical Endocrinology (AACE) announced the publication of the 2023 Comprehensive Type 2 Diabetes Management ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

Tribe brought together global experts to establish consensus recommendations on using diabetes management technology during pregnancy, addressing a critical gap in clinical guidance for expectant ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. An AACE consensus statement and updated algorithms ...